Özlem Türeci Selected Research

Özlem Türeci Research Topics

Disease

55	Neoplasms (Cancer) 05/2024 - 01/2011
22	COVID-19 03/2024 - 10/2020
8	Infections 01/2023 - 01/2019
5	Adenocarcinoma 08/2023 - 09/2019
4	Breakthrough Infections 01/2023 - 01/2022
4	Melanoma (Melanoma, Malignant) 01/2020 - 10/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 02/2014
3	Breast Neoplasms (Breast Cancer) 05/2020 - 09/2015
3	Communicable Diseases (Infectious Diseases) 01/2017 - 10/2014
2	Human Influenza (Influenza) 09/2023 - 01/2020
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 09/2019
2	Headache (Headaches) 01/2021 - 12/2020
2	Pain (Aches) 01/2021 - 12/2020
2	Fatigue 01/2021 - 12/2020
2	Neoplasm Metastasis (Metastasis) 01/2017 - 01/2011
2	Testicular Neoplasms (Testicular Cancer) 11/2015 - 03/2014
1	Myocarditis (Carditis) 03/2024
1	Pericarditis 03/2024
1	Fever (Fevers) 01/2023
1	Hypoxia (Hypoxemia) 08/2022
1	Disease Progression 05/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021
1	Multiple Sclerosis 01/2021
1	Severe Acute Respiratory Syndrome 10/2020
1	Choriocarcinoma 05/2020
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Lymphatic Metastasis 09/2019
1	Carcinoma (Carcinomatosis) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Vaccinia 12/2017
1	Lung Neoplasms (Lung Cancer) 11/2015
1	Triple Negative Breast Neoplasms 09/2015

Drug/Important Bio-Agent (IBA)

33	VaccinesIBA 09/2023 - 01/2011
24	AntigensIBA 11/2023 - 01/2011
17	BNT162 VaccineIBA 03/2024 - 10/2020
17	mRNA VaccinesIBA 03/2024 - 10/2011
16	Messenger RNA (mRNA)IBA 03/2024 - 06/2011
15	RNA (Ribonucleic Acid)IBA 06/2023 - 10/2011
9	EpitopesIBA 01/2022 - 01/2011
8	Proteins (Proteins, Gene)FDA Link 05/2024 - 03/2016
6	zolbetuximabIBA 08/2023 - 02/2014
5	Peptides (Polypeptides)IBA 01/2021 - 01/2016
4	ClaudinsIBA 05/2024 - 02/2014
4	claudin 6IBA 11/2023 - 03/2016
4	Cancer VaccinesIBA 01/2020 - 06/2011
3	Monoclonal AntibodiesIBA 03/2024 - 01/2018
3	Chimeric Antigen ReceptorsIBA 11/2023 - 01/2020
3	Immunoglobulin G (IgG)IBA 09/2023 - 10/2020
3	N-(2-cyanoethylene)urea (BA 1)IBA 12/2022 - 01/2022
3	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2022 - 01/2022
3	AntibodiesIBA 01/2022 - 01/2011
3	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2016
3	cyclopropapyrroloindoleIBA 01/2022 - 01/2020
2	Interleukin-2 (IL2)IBA 03/2024 - 08/2023
2	Tight Junction ProteinsIBA 01/2023 - 01/2020
2	Neutralizing AntibodiesIBA 12/2022 - 01/2020
2	CytokinesIBA 01/2022 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 09/2019 - 12/2014
2	Bispecific AntibodiesIBA 10/2017 - 07/2017
2	flt3 ligand protein (flt3 ligand)IBA 01/2016 - 10/2011
1	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 05/2024
1	LipidsIBA 05/2024
1	TetraspaninsIBA 05/2024
1	Histocompatibility Antigens Class IIBA 03/2024
1	Zoledronic Acid (Zometa)FDA Link 08/2023
1	Recombinant ProteinsIBA 01/2023
1	AcidsIBA 12/2022
1	Immune Sera (Antisera)IBA 12/2022
1	Glycoproteins (Glycoprotein)IBA 12/2022
1	Therapeutic UsesIBA 08/2022
1	COVID-19 VaccinesIBA 01/2022
1	EnzymesIBA 01/2022
1	InterferonsIBA 01/2021
1	Lipid NanoparticlesIBA 10/2020
1	NucleosidesIBA 10/2020
1	LigandsIBA 05/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 05/2020
1	Cystine-Knot MiniproteinsIBA 01/2020
1	Coloring Agents (Dyes)IBA 01/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2020
1	Fibronectins (Fibronectin)IBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	NucleotidesIBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	Toll-Like Receptor 7IBA 01/2019
1	Tumor Biomarkers (Tumor Markers)IBA 03/2016
1	Estrogens (Estrogen)FDA Link 01/2016
1	Antiviral Agents (Antivirals)IBA 01/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2015
1	Tumor Viral Antigens (Large T Antigen)IBA 11/2015
1	TensinsIBA 11/2015
1	AutoantibodiesIBA 11/2015

Therapy/Procedure

23	Immunotherapy 05/2024 - 01/2011
12	Therapeutics 08/2022 - 06/2011
3	Radiotherapy 03/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2023 - 09/2019
1	Transcutaneous Electric Nerve Stimulation (TENS) 12/2020
1	Premedication 01/2020
1	Combination Drug Therapy (Combination Chemotherapy) 09/2019